Biofrontera Competitors and Similar CompaniesClear all
Skyepharma's competitors and similar companies include Affimed N.V. and Zogenix.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ||
Founding Date | Founding Date 1996 | Founding Date 2000 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Heidelberg, DE HQ | Locations Emeryville, US HQ Maidenhead, GB |
Employees | Employees 2453% increase | Employees 76 | Employees 743% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $81.7m (FY, 2021) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods N/A | Cost of goods $4.8m (FY, 2021) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit €13m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income (€105.9m) (FY, 2023) | Net income ($227.4m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Affimed N.V.
HQ
Heidelberg, DE
Employees
76
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View companyZogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company